These findings emphasize the importance of TMAO and resistin as complementary biomarkers in obesity-related metabolic and cardiovascular dysfunction, offering potential value in early risk stratification and targeted intervention strategies. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.